Molecular Health’s MH Guide shortlisted for the German Digital Health Award 2019
- Molecular Health Guide (MH Guide) shortlisted for the German Digital Health Award 2019
- Novartis and Sandoz/Hexal nominate seven out of 119 submissions
- MH Guide enables evidence-based cancer therapy decisions for physicians, patients and health insurers
Molecular Health (MH), a leading company in the field of data science for precision medicine and specializing in the development of products and services leveraging its proprietary biomedicine technology platform Dataome, has been shortlisted for the German Digital Health Award 2019. As Novartis Pharma and Sandoz Germany/Hexal announced earlier, MH Guide is one of only seven entries selected from a total of 119 submissions. The German Digital Health Award is given to sustainable digital solutions to improve healthcare in Germany. The 2nd annual awards ceremony will take place in Berlin on March 20, 2019.